- Home
- CNDT vs ALEC Comparison
CNDT vs ALEC Comparison
Compare CNDT & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CNDT | ALEC |
|---|---|---|
| Founded | 2016 | 2013 |
| Country | United States | United States |
| Employees | 51000 | 103 |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 234.2M | 275.8M |
| IPO Year | 2016 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CNDT | ALEC |
|---|---|---|
| Price | $1.61 | $2.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $4.83 |
| AVG Volume (30 Days) | 935.5K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,042,000,000.00 | $21,045,000.00 |
| Revenue This Year | $2.01 | $2.03 |
| Revenue Next Year | $4.06 | $29.87 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.15 | $1.09 |
| 52 Week High | $2.98 | $3.40 |
Technical Indicators
Market Signals| Indicator | CNDT | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 46.11 | 52.35 |
| Support Level | $1.35 | $2.19 |
| Resistance Level | $1.62 | $2.58 |
| Average True Range (ATR) | 0.11 | 0.21 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 28.57 | 16.52 |
Price Performance
Historical ComparisonAbout CNDT Conduent Incorporated
Conduent Inc acts as a provider of business process services with expertise in transaction-intensive processing, analytics, and automation. The company provides industry-focused service offerings in growth markets such as Healthcare and Transportation, as well as provides multi-industry services such as transaction processing, customer care, and payment services. It operates through three segments, namely Commercial Industries, which is the key revenue-driving segment, Government Services, and Transportation. The group operates its business in the United States, Europe, and Other areas, of which the majority of revenue is generated in the United States.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.